Does SOFOSBUVIR Cause Hepatocellular carcinoma? 877 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 877 reports of Hepatocellular carcinoma have been filed in association with SOFOSBUVIR (Epclusa). This represents 5.1% of all adverse event reports for SOFOSBUVIR.
877
Reports of Hepatocellular carcinoma with SOFOSBUVIR
5.1%
of all SOFOSBUVIR reports
119
Deaths
198
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From SOFOSBUVIR?
Of the 877 reports, 119 (13.6%) resulted in death, 198 (22.6%) required hospitalization, and 65 (7.4%) were considered life-threatening.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SOFOSBUVIR. However, 877 reports have been filed with the FAERS database.
What Other Side Effects Does SOFOSBUVIR Cause?
Fatigue (2,004)
Drug ineffective (1,833)
Hepatitis c (1,662)
Headache (1,417)
Nausea (1,211)
Off label use (1,184)
Anaemia (1,065)
Insomnia (940)
Treatment failure (806)
Dyspnoea (692)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
SOFOSBUVIR\VELPATASVIR (161)
Which SOFOSBUVIR Alternatives Have Lower Hepatocellular carcinoma Risk?
SOFOSBUVIR vs SOFOSBUVIR\VELPATASVIR
SOFOSBUVIR vs SOFOSBUVIR\VELPATASVIR\VOXILAPREVIR
SOFOSBUVIR vs SOLIFENACIN
SOFOSBUVIR vs SOLIRIS
SOFOSBUVIR vs SOLOSTAR